Why the study?
Does CMR-determined scar volume predict ventricular tachycardias in patients with ischemic cardiomyopathy eligible for ICD therapy?
Does CMR-determined scar volume predict ventricular tachycardias in patients with ischemic cardiomyopathy eligible for ICD therapy?
Answers are grounded in this paper and cite their sources.
CMR-determined scar volume and characteristics may improve risk stratification for ventricular tachycardias in patients with ischemic cardiomyopathy.
The interesting data reported by Bernhardt et al. strengthen the diagnostic benefit of CMR in patients with ischemic cardiomyopathy. Consequently, the presence, location and size of the CMR-determined scar tissue may be used for better risk stratification in patients with ischemic cardiomyopathy eligible for ICD therapy.
No takes yet. Share an insight, caveat, or question.
Wall et al. (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: